3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 4
1
Phase 3
1
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Uterine Cervical Neoplasms
1
Ovarian Neoplasms
1
Neoplasms, Neuroepithelial
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
Radiotherapy
8
Temozolomide
7
Lomustine
6
Procarbazine
4
Carmustine
4
Bevacizumab
4
Vincristine
3
Surgical Procedures, Operative
2
Administration, Oral
2
vorasidenib
1
fluorodopa F 18
1
contrast agent BR1
1
carmustine, poliferprosan 20 drug combination
1
Valproic Acid
1
Tranexamic Acid
1
Trabedersen
1
TIC10 compound
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiation
1
Microbubbles
1
Methylphenidate
1
Methods
1
Isotretinoin
1
Infusions, Intravenous
1
IL13-PE38
1
Fentanyl
1
Eflornithine
1
Drug Delivery Systems
1
Donepezil
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Glioma
×
Valproic Acid
×
Clear all
NCT03243461
2022-06-06
HIT-HGG-2013
University of Göttingen
Phase 3
Unknown
167 enrolled